Latest Breaking News On - Annual biopharma conference - Page 9 : comparemela.com

Cabaletta Bio : Strengthened balance sheet by closing $100M public offering extending cash runway into the fourth quarter of 2025

- Strengthened balance sheet by closing $100M public offering extending cash runway into the fourth quarter of 2025 - PHILADELPHIA, Aug. 10,. -Today at 07:19 am- MarketScreener

New yorkUnited statesAnup mardaSteven nichtbergerShawn tomaselloWilliam gramigStern investor relations incAmerican society of geneDrug administrationScience technologyCompany board of directorsGilead sciencesMorgan stanleyCabaletta bio incExchange commissionChief executive officer

Cabaletta Bio Reports Second Quarter 2023 Financial Results and Provides Business Update

– Received second IND application clearance for CABA-201 in myositis as well as Fast Track Designation in SLE and LN – – Strengthened balance sheet by closing $100M public offering extending. -Today at 07:02 am- MarketScreener

New yorkUnited statesAnup mardaSteven nichtbergerWilliam gramigShawn tomaselloExchange commissionCabaletta bio incDrug administrationAmerican society of geneMorgan stanleyScience technologyStern investor relations incCompany board of directorsGilead sciencesFast track designation

Alector, Inc (NASDAQ:ALEC) Q2 2023 Earnings Call Transcript

Operator: Good afternoon, ladies and gentlemen, and welcome to the Alector Midyear 2023 Earnings Conference Call. [Operator Instructions] As a reminder, this conference call is being recorded.

United statesNew yorkKatie hoganMarc grassoYaron werberGary romanoGraig suvannavejhPaul matteisArnon rosenthalGreg harrisonAdam staffaroniTom shraderWilliam blairSara kenkare mitraMyles minterAlector inc

uniQure Inc : uniQure Announces Second Quarter 2023 Financial Results and Highlights Recent Company Progress

uniQure Inc : uniQure Announces Second Quarter 2023 Financial Results and Highlights Recent Company Progress
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

Noord hollandUnited statesNew yorkMatt kapustaJeannette pottsTom maloneLos angelesApic bioChiara russoMariae cantorWalid abi saabDavid cervenyAbbott laboratoriesNovo nordiskGroup viceAmerican society of gene

UniQure Announces Second Quarter 2023 Financial Results and Highlights Recent Company Progress

~ Announced encouraging interim analysis data from ongoing Phase I/II clinical trial of AMT-130 in Huntington’s disease showing preservation of function compared to baseline and clinical benefits.

Noord hollandNew yorkUnited statesJeannette pottsLos angelesChiara russoTom maloneWalid abi saabDavid cervenyMatt kapustaMariae cantorApic bioCounsel at millennium pharmaceuticalsEuropean unionTakeda pharmaceuticalsNovo nordisk